There is evidence that certain alleles at the
HLA-DQ locus are correlated with susceptibility to
insulin-dependent diabetes mellitus (
IDDM) and in particular that DQ beta-chain alleles containing
aspartic acid at position 57 are protective. The availability of a large group of patients with
IDDM enabled us to assess the role of
HLA-DQ alleles in susceptibility to the disease in order to confirm and extend recent observations derived from studies of smaller numbers of patients. Using allele-specific
oligonucleotide probes and the polymerase chain reaction, we studied 266 unrelated patients with
IDDM and 203 unrelated normal subjects for eight
HLA-DQ beta-chain alleles. Two major findings emerged from these studies. First, the presence of an HLA-DQw1.2 allele was protective. Only 6 of the 266 patients with
IDDM (2.3 percent) were positive for HLA-DQw1.2, as compared with 74 of the 203 normal subjects (36.4 percent; P less than 0.001). Thus, persons with the HLA-DQw1.2 allele, which is one of the polymorphic forms of the beta chain of the
HLA-DQ molecule, rarely had
IDDM, no matter which other
HLA-DQ beta-chain allele they inherited ("dominant protection"). Second, the presence of the
HLA-DQw8 allele increased the risk of
IDDM. The relative risk of
IDDM was 5.6 in persons homozygous for
HLA-DQw8, and it was similar in persons with the HLA-DQw1.1/DQw8 or HLA-DQw2/DQw8 haplotype ("dominant susceptibility"). However, the relative risk of
IDDM in persons who had the HLA-DQw1.2/DQw8 haplotype was 0.37, demonstrating that the protective effect of HLA-DQw1.2 predominated over the effect of
HLA-DQw8. We conclude that the presence of the HLA
Class II antigen DQw1.2 is strongly protective against the development of
IDDM, and that complete
HLA-DQ typing is necessary for accurate assessment of susceptibility to
IDDM.